Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie-Laurence Lambert

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Critical Care (London, England)|July 13, 2011
Impact estimates of nosocomial bloodstream infection: looking from a different angleDirk Vogelaers, Marie-Laurence Lambert, Stijn Blot
The Lancet. Infectious Diseases|May 3, 2003
Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidenceKamran Siddiqi, Marie-Laurence Lambert, John Walley
Infection Control and Hospital Epidemiology|May 12, 2021
Seasonal variation of hospital-acquired bloodstream infections: A national cohort studyKoen Blot, Naïma Hammami, Stijn Blot, et al.
Infection Control and Hospital Epidemiology|April 24, 2019
Increasing burden of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecium in hospital-acquired bloodstream infections (2000-2014): A national dynamic cohort studyKoen Blot, Naïma Hammami, Stijn Blot, et al.
Scientific Reports|March 26, 2022
Gram-negative central line-associated bloodstream infection incidence peak during the summer: a national seasonality cohort studyKoen Blot, Naïma Hammami, Stijn Blot, et al.
Infection Control and Hospital Epidemiology|January 14, 2016
Validation of a Sampling Method to Collect Exposure Data for Central-Line-Associated Bloodstream InfectionsNaïma Hammami, Karl Mertens, Rosanna Overholser, et al.
Sexually Transmitted Diseases|March 25, 2005
Street youths are the only high-risk group for HIV in a low-prevalence South American countryMarie-Laurence Lambert, Faustino Torrico, Claire Billot, et al.
Antimicrobial Resistance and Infection Control|April 5, 2013
Variations in catheter-related bloodstream infections rates based on local practicesSoraya Cherifi, Georges Mascart, Anne Dediste, et al.
ERJ Open Research|November 29, 2019
Real-life effectiveness of omalizumab in difficult-to-treat <i>versus</i> severe asthma: a national cohort study in BelgiumKatia M C Verhamme, Catherine Lucet, Alain Van Meerhaeghe, et al.
The Lancet. Infectious Diseases|May 3, 2003
Recurrence in tuberculosis: relapse or reinfection?Marie-Laurence Lambert, Epco Hasker, Armand Van Deun, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Critical Care (London, England)|July 13, 2011
Impact estimates of nosocomial bloodstream infection: looking from a different angleDirk Vogelaers, Marie-Laurence Lambert, Stijn Blot
The Lancet. Infectious Diseases|May 3, 2003
Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidenceKamran Siddiqi, Marie-Laurence Lambert, John Walley
Infection Control and Hospital Epidemiology|May 12, 2021
Seasonal variation of hospital-acquired bloodstream infections: A national cohort studyKoen Blot, Naïma Hammami, Stijn Blot, et al.
Infection Control and Hospital Epidemiology|April 24, 2019
Increasing burden of Escherichia coli, Klebsiella pneumoniae, and Enterococcus faecium in hospital-acquired bloodstream infections (2000-2014): A national dynamic cohort studyKoen Blot, Naïma Hammami, Stijn Blot, et al.
Scientific Reports|March 26, 2022
Gram-negative central line-associated bloodstream infection incidence peak during the summer: a national seasonality cohort studyKoen Blot, Naïma Hammami, Stijn Blot, et al.
Infection Control and Hospital Epidemiology|January 14, 2016
Validation of a Sampling Method to Collect Exposure Data for Central-Line-Associated Bloodstream InfectionsNaïma Hammami, Karl Mertens, Rosanna Overholser, et al.
Sexually Transmitted Diseases|March 25, 2005
Street youths are the only high-risk group for HIV in a low-prevalence South American countryMarie-Laurence Lambert, Faustino Torrico, Claire Billot, et al.
Antimicrobial Resistance and Infection Control|April 5, 2013
Variations in catheter-related bloodstream infections rates based on local practicesSoraya Cherifi, Georges Mascart, Anne Dediste, et al.
ERJ Open Research|November 29, 2019
Real-life effectiveness of omalizumab in difficult-to-treat <i>versus</i> severe asthma: a national cohort study in BelgiumKatia M C Verhamme, Catherine Lucet, Alain Van Meerhaeghe, et al.
The Lancet. Infectious Diseases|May 3, 2003
Recurrence in tuberculosis: relapse or reinfection?Marie-Laurence Lambert, Epco Hasker, Armand Van Deun, et al.
Pageof 2